Bio Pharma Dive
OCTOBER 10, 2023
The pharma plans for the new Berkeley facility to produce clinical, and potentially commercial, supplies of a Parkinson’s disease cell therapy being tested by its subsidiary BlueRock.
Pharmaceutical Technology
OCTOBER 10, 2023
In a two-part column, F. Randy Vogenberg delves into why it is important to address emerging challenges in the employer-based US commercial insurance landscape.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
OCTOBER 10, 2023
There have been few bigger-ticket acquisitions recently. But a string of deals announced in early October may affirm the forecasts of analysts who expect M&A to tick up in the coming months.
Pharmaceutical Technology
OCTOBER 10, 2023
The Gates Foundation is providing $40m in funding to advance the accessibility of Quantoom Biosciences' affordable mRNA vaccine platform.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
AuroBlog - Aurous Healthcare Clinical Trials blog
OCTOBER 10, 2023
It wasn’t that long ago that some people speculated that long COVID was all in the mind – a psychosomatic illness. Thankfully, that period of speculation is now behind us. We have compelling evidence that long COVID is very real and can affect major organs in people who were previously hospitalised with the disease.
Bio Pharma Dive
OCTOBER 10, 2023
The biotech claimed the results still showed promise for its experimental fatty liver disease treatment, but shares sank sharply on the news.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Bio Pharma Dive
OCTOBER 10, 2023
In perioperative setting, Merck says its immunotherapy helps patients live longer, with an approval decision expected later this month.
Rethinking Clinical Trials
OCTOBER 10, 2023
Ethics and regulatory onboarding documentation for the NIH Pragmatic Trials Collaboratory’s newest Demonstration Projects are now available. The documents include meeting minutes and supplementary materials summarizing recent discussions of ethics and regulatory issues associated with the BEST-ICU, Chat 4 Heart Health, and TAICHIKNEE studies. The consultations took place by video conference and included representation from the studies’ principal investigators, members of the NIH Coll
Pharmaceutical Technology
OCTOBER 10, 2023
The companies will develop multiple monoclonal antibodies against membrane proteins, such as GPCRs and SLC transporters.
Pharma Times
OCTOBER 10, 2023
The scheme will help ten projects establish research and innovation clusters - News - PharmaTimes
Pharmaceutical Technology
OCTOBER 10, 2023
The logistics service is taking another step in becoming a leader in healthcare and pharmaceutical logistics.
pharmaphorum
OCTOBER 10, 2023
Embracing the challenges and opportunities of digital health Mike.
Pharmaceutical Technology
OCTOBER 10, 2023
ABVC BioPharma has obtained a patent in Taiwan for the usage of PDC-1421 in ABV-1504, an asset intended for major depressive disorder.
Pharma Times
OCTOBER 10, 2023
Researchers focused on four of the most common heart conditions in the UK - News - PharmaTimes
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Pharmaceutical Technology
OCTOBER 10, 2023
The partnership builds on their existing drug discovery agreement to develop a neurological disease target.
Fierce Pharma
OCTOBER 10, 2023
What doctors described as a “messy” treatment landscape in early-stage non-small cell lung cancer (NSCLC) could get clearer thanks to a first-in-class overall survival win from Merck & Co.’s Ke | What doctors described as a “messy” treatment landscape in early-stage non-small cell lung cancer could get clearer thanks to a first-in-class overall survival win from Merck & Co.’s Keytruda.
Pharmaceutical Technology
OCTOBER 10, 2023
Theramex has added the synthetic hormones to its portfolio as Viatris divests its businesses and sells assets.
pharmaphorum
OCTOBER 10, 2023
Economist Impact’s Future of Health Europe summit: Building a sustainable, inclusive, and digital health system Mike.
Pharmaceutical Technology
OCTOBER 10, 2023
As sponsors seek to minimize trial delays and get new therapies to market faster, we explore whether increased adoption of a more patient-centric approach could make a difference to timelines.
pharmaphorum
OCTOBER 10, 2023
The digital skills you need for customer centric sales Mike.
Pharmaceutical Technology
OCTOBER 10, 2023
Bayer has invested $250m in a manufacturing plant at Berkeley, California, US, to produce cell therapies for use across the globe.
pharmaphorum
OCTOBER 10, 2023
South Korea: Emerging global leader in life sciences Mike.
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Pharmaceutical Technology
OCTOBER 10, 2023
CanariaBio has entered into a distribution and licence agreement with Hikma MENA FZE for oregovomab to treat advanced ovarian cancer.
Fierce Pharma
OCTOBER 10, 2023
Despite the promise of cell therapies, manufacturing the personalized medicines at scale has been a limiting factor for many companies. | Despite the promise of cell therapies, manufacturing the personalized medicines at scale has been a limiting factor for many companies. Now, as BlueRock Therapeutics advances its lead prospect, its parent company Bayer is ready to kick production into high gear.
Pharmaceutical Technology
OCTOBER 10, 2023
Robots are already vital in a number of sectors, from manufacturing to retail, and their use will only grow.
ACRP blog
OCTOBER 10, 2023
In recognition of October being Breast Cancer Awareness Month , ACRP recently went behind the scenes with a clinical research coordinator on the study team for a bold Cleveland Clinic investigation of a vaccine aimed at preventing triple-negative breast cancer (TNBC), the most aggressive and lethal form of the disease. Emily (Esakov) Rhoades, PhD, Multisite Investigator Initiated Trial (IIT) Program Manager for the Cleveland Clinic’s Taussig Cancer Institute, provided insights on how the study,
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Pharmaceutical Technology
OCTOBER 10, 2023
The Scottish Medicines Consortium accepted 12 new treatments for conditions ranging from cancer to obesity.
pharmaphorum
OCTOBER 10, 2023
Bayer backs cell therapy ambition with $250m US facility Phil.
Pharmaceutical Technology
OCTOBER 10, 2023
Kim and colleagues investigated the efficacy and tolerability of an initial TCT with metformin, dapagliflozin, and saxagliptin.
Intouch Solutions
OCTOBER 10, 2023
Fact 1: Pharma is in the business of discovering, developing, and producing drugs with the aim of treating, curing, or preventing diseases…ultimately leading to healthier communities around the world. Fact 2: Pharma is just that – a business. Both facts are true. Both facts co-exist. And both facts impact how society views our industry. On that last point, there have clearly been times where Fact 2 has a direct influence on Fact 1.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Expert insights. Personalized for you.
297 
Let's personalize your content